Dimethyl Fumarate Capsule
Product Images NDC 68462-307

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 68462-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120-14-bottle (120 14 Bottle)

This is a medication called Dimethyl Fumarate manufactured by Glenmark. It comes in the form of delayed-release capsules with a strength of 20mg each. The National Drug Code or NDC number for this medication is 68462-307-41. The prescription is for only 14 capsules and should be swallowed whole.*

FDA Label Image

240-60-bottle (240 60 Bottle)

NDC 68462-308-60 is a prescription medicine that comes in the form of Delayed-Release Capsules containing Dimethyl Fumarate. The medication should be swallowed whole and is manufactured by Glenmark. No other information is available in the given text.*

FDA Label Image

30-day-starter-pack (30 Day Starter Pack)

This is a description of a medication package containing Dimethyl Fumarate Delayed-Release Capsules. The package is a 30-day starter pack and includes two bottles of Stasor Doss 120 mg and Regular Dose 260 mg containing 14 and 46 capsules of 120 mg each and 240 mg each, respectively. The package includes instructions for use, which require taking one 120 mg capsule by mouth twice a day for the first seven days and then taking one 240 mg capsule twice a day. The medication is manufactured by Glenmark Pharmaceuticals Inc. in India. For further information, contact the manufacturer's customer service.*

FDA Label Image

Figure_1 (Figure1)

This appears to be a graph showing the percentage of subjects with confirmed progression of disability over time on the study for a placebo group and a group receiving dimethyl fumarate 240 mg BID. The percentages are given for various time points up to week 72.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

Not available. The text provided is incomplete and does not provide any useful information.*

FDA Label Image

Structural-formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.